CNB Bank’s GSK GSK Stock Holding History

CNB Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.2K	Hold	728	–	–	0.01%	325
2026 Q1	$40.2K	Hold	728	–	–	0.02%	325
2025 Q4	$35.7K	Hold	728	–	–	0.01%	330
2025 Q3	$31.4K	Buy	+728	New	+$28.4K	0.01%	327
2024 Q1	–	Sell	-140	Closed	-$5.19K	–	504
2023 Q4	$5.19K	Hold	140	–	–	﹤0.01%	406
2023 Q3	$5.08K	Hold	140	–	–	﹤0.01%	410
2023 Q2	$4.99K	Sell	140 -132	-49%	-$4.74K	﹤0.01%	371
2023 Q1	$9.68K	Hold	272	–	–	0.01%	350
2022 Q4	$9.56K	Buy	+272	New	+$9.06K	0.01%	332
2022 Q3	–	Sell	-272	Closed	-$15K	–	468
2022 Q2	$15K	Hold	272	–	–	0.01%	298
2022 Q1	$15K	Hold	272	–	–	0.01%	305
2021 Q4	$15K	Hold	272	–	–	0.01%	306
2021 Q3	$13K	Hold	272	–	–	0.01%	319
2021 Q2	$14K	Sell	272 -120	-31%	-$5.77K	0.01%	315
2021 Q1	$17K	Buy	392 +120	+44%	+$5.45K	0.01%	291
2020 Q4	$13K	Hold	272	–	–	0.01%	303
2020 Q3	$13K	Sell	272 -58	-18%	-$2.91K	0.01%	293
2020 Q2	$17K	Sell	330 -294	-47%	-$15.1K	0.02%	293
2020 Q1	$30K	Buy	624 +180	+41%	+$9.6K	0.03%	235
2019 Q4	$26K	Hold	444	–	–	0.02%	263
2019 Q3	$24K	Hold	444	–	–	0.02%	262
2019 Q2	$22K	Buy	444 +114	+35%	+$5.72K	0.02%	295
2019 Q1	$17K	Buy	330 +132	+67%	+$6.6K	0.01%	251
2018 Q4	$9K	Hold	198	–	–	0.01%	262
2018 Q3	$10K	Hold	198	–	–	0.01%	236
2018 Q2	$10K	Hold	198	–	–	0.01%	234
2018 Q1	$10K	Hold	198	–	–	0.01%	223
2017 Q4	$9K	Buy	+198	New	+$9.15K	0.01%	253

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CNB Bank's GSK Position: Q2 2026 in Review

CNB Bank held its GSK (GSK) position steady in Q2 2026 at 728 shares worth $38.2K. The position accounts for 0.01% of the portfolio, ranked #325.

CNB Bank first reported a position in GSK in Q4 2017 and has held it in 28 quarters since. The position peaked at $40.2K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

CNB Bank held 728 shares of GSK worth $38.2K as of Q2 2026.
CNB Bank left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of CNB Bank's portfolio in Q2 2026, its #325 holding.
CNB Bank first reported a position in GSK in Q4 2017 and has held it in 28 quarters since.
CNB Bank's GSK position peaked at $40.2K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.